Market sentiment signals for Arrowhead Pharma (ARWR): analyst consensus, short interest, options flow and insider activity.
Analyst Consensus
Buy
20 analysts
Options Flow (P/C)
0.16
More calls — Bullish
Avg Consensus PT
$89
+59.3%
Highest Price Target
$126
+124.8%
Lowest Price Target
$17
-69.7%
Short Interest
10.6%
Rising — Bearish
Insider Activity (30d)
—
Short Interest — % of Float
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Oct 15, 2026 | UBS | John Lee— | +94.4% | $63 → $109 | Assumes | Buy |
| Oct 15, 2026 | Chardan Capital | Keay Nakae— | +105.1% | $115 → $115 | Maintained | Buy |
